Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Tildrakizumab (trade name Ilumya (USA)/Ilumetri (European Union)) is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders. In the United States, it is approved for the treatment of moderate-to-severe plaque psoriasis.
This report elaborates on the current development of the Tildrakizumab industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Sun Pharma
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Prefilled 100 mg/mL solution
Type II
Application:
Hospital
Drug store
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Tildrakizumab Industry Overview
-
1.1.1 Tildrakizumab Market Scope and Market Segments
-
1.1.2 Tildrakizumab Industry Characteristics
-
1.1.3 Global and China Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Tildrakizumab Production Value and Growth Rate (2017-2028)
-
1.2 Global Tildrakizumab Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Prefilled 100 mg/mL solution
-
1.2.2 Type II
-
1.3 Global Tildrakizumab Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospital
-
1.3.2 Drug store
-
1.4 Market Analysis by Region
-
1.4.1 North America Tildrakizumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Tildrakizumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Tildrakizumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Tildrakizumab Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Tildrakizumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Tildrakizumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Tildrakizumab Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Tildrakizumab Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Tildrakizumab Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Tildrakizumab Industry Porter's Five Forces Model Analysis
-
2.2.3 Tildrakizumab Industry PEST Analysis
-
2.3 Tildrakizumab Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Tildrakizumab Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Tildrakizumab Industry
Chapter 3 Global and China Tildrakizumab Market, by Manufacturer
-
3.1 Global and China Tildrakizumab Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Tildrakizumab Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Tildrakizumab Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Tildrakizumab Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Tildrakizumab Market Top 3 Players
Chapter 4 Global and China Tildrakizumab Market, by Type (2017-2028)
-
4.1 Tildrakizumab Market Trend, by Type
-
4.2 Global Tildrakizumab Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Tildrakizumab Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Tildrakizumab Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Tildrakizumab Price Trend, by Type (2017-2028)
-
4.3 China Tildrakizumab Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Tildrakizumab Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Tildrakizumab Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Tildrakizumab Price Trend, by Type (2017-2028)
Chapter 5 Global and China Tildrakizumab Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Tildrakizumab Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Tildrakizumab Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Tildrakizumab Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Tildrakizumab Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Tildrakizumab Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Tildrakizumab Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Tildrakizumab Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Tildrakizumab Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Tildrakizumab Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Tildrakizumab Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Tildrakizumab Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Tildrakizumab Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Tildrakizumab Market Analysis
-
7.1 North America Tildrakizumab Market, by Type
-
7.2 North America Tildrakizumab Market, by Application
-
7.3 North America Tildrakizumab Market Analysis and Forecast, by Country
-
7.3.1 United States Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Tildrakizumab Market Analysis
-
8.1 Europe Tildrakizumab Market, by Type
-
8.2 Europe Tildrakizumab Market, by Application
-
8.3 Europe Tildrakizumab Market Analysis and Forecast, by Country
-
8.3.1 Germany Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Tildrakizumab Market Analysis
-
9.1 APAC Tildrakizumab Market, by Type
-
9.2 APAC Tildrakizumab Market, by Application
-
9.3 APAC Tildrakizumab Market Analysis and Forecast, by Country
-
9.3.1 China Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Tildrakizumab Market Analysis
-
10.1 Latin America, Middle East and Africa Tildrakizumab Market, by Type
-
10.2 Latin America, Middle East and Africa Tildrakizumab Market, by Application
-
10.3 Latin America, Middle East and Africa Tildrakizumab Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Tildrakizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Tildrakizumab Company Profiles
-
11.1 Sun Pharma
-
11.1.1 Sun Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Sun Pharma Tildrakizumab Product Profiles, Application and Specification
-
11.1.3 Sun Pharma Tildrakizumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Tildrakizumab Industry Investment Prospect and Risk Assessment
-
12.1 Tildrakizumab Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Tildrakizumab Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure China Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Global Tildrakizumab Production Value and Growth Rate (2017-2028)
-
Figure China Tildrakizumab Production Value and Growth Rate (2017-2028)
-
Figure Global Tildrakizumab Market Size and Growth Rate of Prefilled 100 mg/mL solution (2017-2028)
-
Figure Global Tildrakizumab Market Size and Growth Rate of Type II (2017-2028)
-
Figure Global Tildrakizumab Market Size and Growth Rate of Hospital (2017-2028)
-
Figure Global Tildrakizumab Market Size and Growth Rate of Drug store (2017-2028)
-
Figure North America Tildrakizumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Tildrakizumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Tildrakizumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Tildrakizumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Tildrakizumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Tildrakizumab Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Tildrakizumab Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Tildrakizumab Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Tildrakizumab Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Tildrakizumab Market Share, by Manufacturer in 2021
-
Figure Global and China Tildrakizumab Market Share, by Manufacturer in 2022
-
Table Global Tildrakizumab Sales Volume, by Type (2017-2028)
-
Table Global Tildrakizumab Sales Volume Share, by Type (2017-2028)
-
Figure Global Tildrakizumab Sales Volume Share, by Type (2017-2028)
-
Table Global Tildrakizumab Sales Value, by Type (2017-2028)
-
Table Global Tildrakizumab Sales Value Share, by Type (2017-2028)
-
Figure Global Tildrakizumab Price Trend, by Type (2017-2028)
-
Table China Tildrakizumab Sales Volume, by Type (2017-2028)
-
Table China Tildrakizumab Sales Volume Share, by Type (2017-2028)
-
Figure China Tildrakizumab Sales Volume Share, by Type (2017-2028)
-
Table China Tildrakizumab Sales Value, by Type (2017-2028)
-
Table China Tildrakizumab Sales Value Share, by Type (2017-2028)
-
Figure China Tildrakizumab Price Trend, by Type (2017-2028)
-
Table Global Tildrakizumab Sales Volume, by Application (2017-2028)
-
Table Global Tildrakizumab Sales Volume Share, by Application (2017-2028)
-
Figure Global Tildrakizumab Sales Volume Share, by Application (2017-2028)
-
Table Global Tildrakizumab Sales Value, by Application (2017-2028)
-
Table Global Tildrakizumab Sales Value Share, by Application (2017-2028)
-
Figure Global Tildrakizumab Sales Value Share, by Application (2017-2028)
-
Table China Tildrakizumab Sales Volume, by Application (2017-2028)
-
Table China Tildrakizumab Sales Volume Share, by Application (2017-2028)
-
Figure China Tildrakizumab Sales Volume Share, by Application (2017-2028)
-
Table China Tildrakizumab Sales Value, by Application (2017-2028)
-
Table China Tildrakizumab Sales Value Share, by Application (2017-2028)
-
Figure China Tildrakizumab Sales Value Share, by Application (2017-2028)
-
Figure China Tildrakizumab Production, Import, Consumption and Export (2017-2022)
-
Figure North America Tildrakizumab Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Tildrakizumab Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Tildrakizumab Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Tildrakizumab Production, Import, Consumption and Export (2017-2022)
-
Table North America Tildrakizumab Sales Volume, by Type (2017-2028)
-
Table North America Tildrakizumab Sales Volume Share, by Type (2017-2028)
-
Figure North America Tildrakizumab Sales Volume Share, by Type (2017-2028)
-
Table North America Tildrakizumab Sales Volume, by Application (2017-2028)
-
Table North America Tildrakizumab Sales Volume Share, by Application (2017-2028)
-
Figure North America Tildrakizumab Sales Volume Share, by Application (2017-2028)
-
Figure United States Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure United States Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure Canada Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Table Europe Tildrakizumab Sales Volume, by Type (2017-2028)
-
Table Europe Tildrakizumab Sales Volume Share, by Type (2017-2028)
-
Figure Europe Tildrakizumab Sales Volume Share, by Type (2017-2028)
-
Table Europe Tildrakizumab Sales Volume, by Application (2017-2028)
-
Table Europe Tildrakizumab Sales Volume Share, by Application (2017-2028)
-
Figure Europe Tildrakizumab Sales Volume Share, by Application (2017-2028)
-
Figure Germany Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure UK Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure UK Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure France Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure France Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure Italy Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure Spain Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure Poland Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure Russia Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Table APAC Tildrakizumab Sales Volume, by Type (2017-2028)
-
Table APAC Tildrakizumab Sales Volume Share, by Type (2017-2028)
-
Figure APAC Tildrakizumab Sales Volume Share, by Type (2017-2028)
-
Table APAC Tildrakizumab Sales Volume, by Application (2017-2028)
-
Table APAC Tildrakizumab Sales Volume Share, by Application (2017-2028)
-
Figure APAC Tildrakizumab Sales Volume Share, by Application (2017-2028)
-
Figure China Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure China Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure Japan Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure India Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure India Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Tildrakizumab Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Tildrakizumab Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Tildrakizumab Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Tildrakizumab Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Tildrakizumab Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Tildrakizumab Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Tildrakizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Tildrakizumab Sales Value and Growth Rate (2017-2028)
-
Table Sun Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sun Pharma Product Profiles, Application and Specification
-
Table Sun Pharma Tildrakizumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
